NO180679C - Pyranylcyanoguanidin-derivater, preparater som inneholder dem og anvendelse derav - Google Patents
Pyranylcyanoguanidin-derivater, preparater som inneholder dem og anvendelse deravInfo
- Publication number
- NO180679C NO180679C NO920767A NO920767A NO180679C NO 180679 C NO180679 C NO 180679C NO 920767 A NO920767 A NO 920767A NO 920767 A NO920767 A NO 920767A NO 180679 C NO180679 C NO 180679C
- Authority
- NO
- Norway
- Prior art keywords
- preparations containing
- cyanoguanidine derivatives
- pyranyl
- pyranyl cyanoguanidine
- derivatives
- Prior art date
Links
- PSUZFEOOWHGNNG-UHFFFAOYSA-N 1-cyano-1-(2h-pyran-2-yl)guanidine Chemical class NC(=N)N(C#N)C1OC=CC=C1 PSUZFEOOWHGNNG-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000002253 anti-ischaemic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/661,763 US5140031A (en) | 1989-05-31 | 1991-02-27 | Pyranyl cyanoguanidine derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO920767D0 NO920767D0 (no) | 1992-02-26 |
| NO920767L NO920767L (no) | 1992-08-28 |
| NO180679B NO180679B (no) | 1997-02-17 |
| NO180679C true NO180679C (no) | 1997-05-28 |
Family
ID=24655020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO920767A NO180679C (no) | 1991-02-27 | 1992-02-26 | Pyranylcyanoguanidin-derivater, preparater som inneholder dem og anvendelse derav |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5140031A (ko) |
| EP (1) | EP0501797B1 (ko) |
| KR (1) | KR920016437A (ko) |
| CN (1) | CN1035253C (ko) |
| AT (1) | ATE138919T1 (ko) |
| AU (1) | AU650512B2 (ko) |
| CA (1) | CA2061699C (ko) |
| CY (1) | CY1952A (ko) |
| DE (1) | DE69211182T2 (ko) |
| DK (1) | DK0501797T3 (ko) |
| ES (1) | ES2088537T3 (ko) |
| GR (1) | GR3020647T3 (ko) |
| HK (1) | HK161396A (ko) |
| IE (1) | IE920346A1 (ko) |
| IL (1) | IL101012A0 (ko) |
| MX (1) | MX9200817A (ko) |
| NO (1) | NO180679C (ko) |
| TW (1) | TW201741B (ko) |
| ZA (1) | ZA921333B (ko) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643921A (en) * | 1990-09-26 | 1997-07-01 | E.R. Squibb & Sons, Inc. | Cardiopulmonary bypass and organ transplant using a potassium channel activator |
| US5401848A (en) * | 1990-11-26 | 1995-03-28 | E. R. Squibb & Sons, Inc. | Indane and quinoline derivatives |
| US5262419A (en) * | 1992-06-11 | 1993-11-16 | E. R. Squibb & Sons, Inc. | Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator |
| US5374643A (en) * | 1992-09-11 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Aryl urea (thiourea) and cyanoguanidine derivatives |
| US5453421A (en) * | 1992-09-11 | 1995-09-26 | E. R. Squibb & Sons, Inc. | Aryl and heterocyclic substituted propenamide derivatives |
| US5463059A (en) * | 1992-11-10 | 1995-10-31 | E. R. Squibb & Sons, Inc. | Process for the preparation of intermediates useful in the preparation of pyranyl cyanoguanidine derivatives |
| US5514690A (en) * | 1992-11-17 | 1996-05-07 | E. R. Squibb & Sons, Inc. | Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline |
| IL109229A0 (en) * | 1993-05-11 | 1994-07-31 | Bristol Myers Squibb Co | Heterocyclic compounds and processes for the preparation of pyranyl cyanoguanidine derivatives using the same |
| US5393771A (en) * | 1993-05-12 | 1995-02-28 | Brisol-Myers Squibb Company | 4-substituted benzopyran and related compounds |
| US5478734A (en) * | 1993-06-18 | 1995-12-26 | Bristol-Myers Squibb Company | Method of chiral epoxidation of benzopyran or pyranopyridine derivatives using microorganisms |
| TW310327B (ko) * | 1993-06-18 | 1997-07-11 | Bristol Myers Squibb Co | |
| US5691344A (en) * | 1993-08-19 | 1997-11-25 | Janssen Pharmaceutica, N.V. | Vasoconstrictive substituted dihydropyranopyridines |
| US5401758A (en) * | 1993-10-07 | 1995-03-28 | Bristol-Myers Squibb Company | Pyridinyl cyanoguanidine compounds |
| US5837702A (en) * | 1993-10-07 | 1998-11-17 | Bristol-Myers Squibb Co. | 4-arylamino-benzopyran and related compounds |
| US5547966A (en) * | 1993-10-07 | 1996-08-20 | Bristol-Myers Squibb Company | Aryl urea and related compounds |
| US5679706A (en) * | 1994-09-30 | 1997-10-21 | Bristol-Myers Squibb Company | Combination of a potassium channel activator and an antiarrhythmic agent |
| US5629429A (en) * | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
| US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
| US5612323A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phosphinic ester substituted benzopyran derivatives |
| US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
| CA2341678C (en) | 1998-09-01 | 2009-10-13 | Bristol-Myers Squibb Company | Potassium channel inhibitors and method |
| US6417207B1 (en) | 1999-05-12 | 2002-07-09 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| US6645968B2 (en) * | 1999-08-03 | 2003-11-11 | Abbott Laboratories | Potassium channel openers |
| MXPA02001207A (es) * | 1999-08-03 | 2002-07-30 | Abbott Lab | Abridores de canal de potasio. |
| DE60007168T2 (de) * | 1999-10-21 | 2004-12-30 | Dongbu Hannong Chemical Co., Ltd. | Benzopyranyl-guanidin-derivate, verfahren zu deren herstellung sowie diese enthaltenden pharmazeutische zusammensetzungen |
| KR100429609B1 (ko) * | 1999-10-21 | 2004-05-03 | 동부한농화학 주식회사 | 벤조피라닐 구아니딘 유도체, 그의 제조방법 및 그를포함하는 약학적 조성물 |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| CN1854135B (zh) * | 2005-04-18 | 2013-06-12 | 李伟章 | 由氰基胍连接组成的杂环化合物及其医药应用 |
| EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
| US7999107B2 (en) | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| US8795627B2 (en) | 2007-03-21 | 2014-08-05 | Raptor Pharmaceuticals Inc. | Treatment of liver disorders by administration of RAP conjugates |
| US20110020453A1 (en) * | 2009-02-06 | 2011-01-27 | Steven Blum | Topical Formulations Comprising Ion Channel Modulators |
| AU2010216512B2 (en) | 2009-02-20 | 2016-06-30 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
| WO2010129819A2 (en) | 2009-05-06 | 2010-11-11 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3682331D1 (de) * | 1985-06-08 | 1991-12-12 | Beecham Group Plc | Pyrano(3,2-c)pyridinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. |
| US4639701A (en) * | 1985-08-30 | 1987-01-27 | Westinghouse Electric Corp. | Circuit breaker with interface flux shunt trip |
| GB8521857D0 (en) * | 1985-09-03 | 1985-10-09 | Beecham Group Plc | Active compounds |
| GB8613786D0 (en) * | 1986-06-06 | 1986-07-09 | Beecham Group Plc | Active compounds |
| GB8625185D0 (en) * | 1986-10-21 | 1986-11-26 | Beecham Group Plc | Active compounds |
| US4988723A (en) * | 1988-06-02 | 1991-01-29 | Fujisawa Pharmaceutical Co., Ltd. | Benzopyran derivatives and their use as anti-hypertensives |
| DE3823533A1 (de) * | 1988-07-12 | 1990-02-08 | Beiersdorf Ag | Substituierte 4-heterocyclyl-2h-benzo(b)pyrane, verfahren und 4-hydroxy-3-brom-, 3,4-oxiranyl-3,4-dehydro-2h-benzo(b)pyrane als zwischenprodukte zu ihrer herstellung, sowie sie enthaltende pharmazeutsche praeparate |
| CA1336963C (en) * | 1988-07-18 | 1995-09-12 | Gary James Grover | Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion |
| DE68926729T2 (de) * | 1988-09-16 | 1997-02-13 | Beecham Group Plc | Benzopyranderivate mit einer blutdrucksenkenden Wirkung |
| US5104890A (en) * | 1989-03-28 | 1992-04-14 | Fujisawa Pharmaceutical Company, Ltd. | Benzopyran derivatives and processes for preparation thereof |
| CA2015296C (en) * | 1989-05-31 | 2001-08-07 | Karnail Atwal | Pyranyl cyanoguanidine derivatives |
| US5095016A (en) * | 1989-08-11 | 1992-03-10 | Kaken Pharmaceutical Co., Ltd. | Benzopyran compounds, processes for their production and pharmaceutical compositions |
| CN1080721C (zh) * | 1995-07-03 | 2002-03-13 | 旭化成株式会社 | 1－(5－异喹啉磺酰基)高哌嗪盐酸盐水合物 |
-
1991
- 1991-02-27 US US07/661,763 patent/US5140031A/en not_active Expired - Lifetime
-
1992
- 1992-02-01 TW TW081100798A patent/TW201741B/zh active
- 1992-02-19 IL IL101012A patent/IL101012A0/xx unknown
- 1992-02-24 AU AU11147/92A patent/AU650512B2/en not_active Ceased
- 1992-02-24 CA CA002061699A patent/CA2061699C/en not_active Expired - Fee Related
- 1992-02-24 ZA ZA921333A patent/ZA921333B/xx unknown
- 1992-02-24 IE IE034692A patent/IE920346A1/en not_active Application Discontinuation
- 1992-02-26 KR KR1019920002992A patent/KR920016437A/ko active IP Right Grant
- 1992-02-26 NO NO920767A patent/NO180679C/no unknown
- 1992-02-26 MX MX9200817A patent/MX9200817A/es not_active IP Right Cessation
- 1992-02-27 AT AT92301654T patent/ATE138919T1/de not_active IP Right Cessation
- 1992-02-27 EP EP92301654A patent/EP0501797B1/en not_active Expired - Lifetime
- 1992-02-27 ES ES92301654T patent/ES2088537T3/es not_active Expired - Lifetime
- 1992-02-27 CN CN92101340A patent/CN1035253C/zh not_active Expired - Fee Related
- 1992-02-27 DK DK92301654.7T patent/DK0501797T3/da active
- 1992-02-27 DE DE69211182T patent/DE69211182T2/de not_active Expired - Fee Related
-
1996
- 1996-07-29 GR GR960402003T patent/GR3020647T3/el unknown
- 1996-08-29 HK HK161396A patent/HK161396A/xx not_active IP Right Cessation
-
1997
- 1997-05-16 CY CY195297A patent/CY1952A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9200817A (es) | 1992-08-01 |
| AU650512B2 (en) | 1994-06-23 |
| CA2061699C (en) | 2002-05-21 |
| CA2061699A1 (en) | 1992-08-28 |
| IL101012A0 (en) | 1992-11-15 |
| NO180679B (no) | 1997-02-17 |
| ES2088537T3 (es) | 1996-08-16 |
| IE920346A1 (en) | 1992-09-09 |
| EP0501797B1 (en) | 1996-06-05 |
| US5140031A (en) | 1992-08-18 |
| CN1064272A (zh) | 1992-09-09 |
| CY1952A (en) | 1997-05-16 |
| NO920767L (no) | 1992-08-28 |
| ATE138919T1 (de) | 1996-06-15 |
| NO920767D0 (no) | 1992-02-26 |
| AU1114792A (en) | 1992-09-03 |
| DK0501797T3 (da) | 1996-06-24 |
| DE69211182T2 (de) | 1997-01-23 |
| ZA921333B (en) | 1992-11-25 |
| TW201741B (ko) | 1993-03-11 |
| CN1035253C (zh) | 1997-06-25 |
| KR920016437A (ko) | 1992-09-24 |
| GR3020647T3 (en) | 1996-10-31 |
| EP0501797A1 (en) | 1992-09-02 |
| DE69211182D1 (de) | 1996-07-11 |
| HK161396A (en) | 1996-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO180679C (no) | Pyranylcyanoguanidin-derivater, preparater som inneholder dem og anvendelse derav | |
| ATE269290T1 (de) | Benzoylderivate | |
| DK0401010T3 (da) | Pyranyl-cyanoguanidin-derivater | |
| DK0471236T3 (da) | Imidazopyridinderivater og deres anvendelse | |
| ATE168992T1 (de) | 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline | |
| FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
| CA2037975A1 (en) | 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors | |
| ATE38519T1 (de) | Azahomoerythromycin-b-derivate und zwischenprodukte. | |
| ATE73768T1 (de) | 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8inter-m-phenylene-pgi2-derivate. | |
| ES2003063A4 (es) | Derivados de pirrolidin-2-ona, que tengan actividad nootropica. | |
| FI921948A0 (fi) | Nya 2-merkaptometylen-tetrahydro- naftalen- och indan-2-karboxamidderivat anvaendbara som enkefalinas- inhibitorer. | |
| ES2141228T3 (es) | Derivados del benzopirano. |